Menu
Currency
GWAS Study

Identification of Two Genetic Loci Associated with Leukopenia after Chemotherapy in Breast Cancer Patients.

Fasching PA, Liu D, Scully S et al.

35653140 PubMed ID
GWAS Study Type
3322 Participants
41 Views
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

FP
Fasching PA
LD
Liu D
SS
Scully S
IJ
Ingle JN
LP
Lyra PC
RB
Rack B
HA
Hein A
EA
Ekici AB
RA
Reis A
SA
Schneeweiss A
TH
Tesch H
FT
Fehm TN
HG
Heinrich G
BM
Beckmann MW
RM
Ruebner M
HH
Huebner H
LD
Lambrechts D
ME
Madden E
SJ
Shen J
RJ
Romm J
DK
Doheny K
JG
Jenkins GD
CE
Carlson EE
LL
Li L
FB
Fridley BL
CJ
Cunningham JM
JW
Janni W
MA
Monteiro ANA
SD
Schaid DJ
HL
Häberle L
WR
Weinshilboum RM
WL
Wang L
Chapter II

Abstract

Summary of the research findings

Purpose: To identify molecular predictors of grade 3/4 neutropenic or leukopenic events (NLE) after chemotherapy using a genome-wide association study (GWAS).

1,679 European ancestry cases with events, 1,643 European ancestry cases without events

Chapter III

Study Statistics

Key metrics and study information

3322
Total Participants
GWAS
Study Type
No
Replicated
European
Ancestry
Germany
Recruitment Country
Chapter IV

AI-Generated Summary

AI-generated by DNAGENICS

Independent AI summary of health and genetic findings from the published study

Important: This summary is AI-generated by DNAGENICS for informational purposes only. It was not created by, affiliated with, or endorsed by the researchers behind the original publication, and is based solely on that published research. It may contain errors or omissions. DNAGENICS disclaims all liability for any inaccuracies or consequences arising from use of this information. Verify all information against the original publication. This is not professional scientific review or medical advice.

AI Summary In Progress

Our AI-generated summary of this publication is being prepared. Please check back soon.